α‐SMA (−) Vimentin (+) was used as a marker of AF, and α‐SMA (+) Vimentin (+) was used as a marker of AF phenotypic transformation (transformation into myofibroblasts). This evidence concerns the gene ACTA1 and atrial fibrillation.